Chopra Daveen 4
4 · Edwards Lifesciences Corp · Filed May 6, 2024
Insider Transaction Report
Form 4
Chopra Daveen
CVP, TMTT
Transactions
- Tax Payment
Common Stock
2024-05-03$85.06/sh−291$24,752→ 22,459 total - Exercise/Conversion
Common Stock
2024-05-04+4,713→ 27,172 total - Tax Payment
Common Stock
2024-05-04$85.25/sh−2,321$197,865→ 24,851 total - Exercise/Conversion
Performance Rights
2024-05-04−4,713→ 0 totalFrom: 2024-05-04Exp: 2028-05-03→ Common Stock (4,713 underlying)
Footnotes (1)
- [F1]On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.